Feb 23 (Reuters) - Cyclopharm:
- FY SALES REVENUE OF A$17.70 MILLION, UP 20.6%
- FINAL DIVIDEND MAINTAINED AT 0.5 AU CENTS PER SHARE
- REVENUE FROM TECHNEGAS GENERATOR & PAS SALES IS EXPECTED TO CONTINUE TO REBOUND TO PRE‐PANDEMIC LEVELS OR BEYOND IN 2022
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
80.5¢ |
Change
-0.035(4.17%) |
Mkt cap ! $90.02M | |||
| Open | High | Low | Value | Volume |
| 84.0¢ | 84.0¢ | 77.5¢ | $114.2K | 141.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5940 | 80.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 81.0¢ | 1223 | 2 |
View Market Depth
| Last trade - 13.32pm 11/09/2025 (20 minute delay) ? |
| CYC (ASX) Chart |